Gland Pharma’s net profit falls 72 percent to Rs. 79 crore in Q4FY23 According to the company’s statement, core markets of US, Europe, Canada, Australia, and New Zealand accounted for 70% of revenue… May 18, 2023 19:23 IST
Gland Pharma’s net profit declines 15 percent; Shares hit 52-week low According to the company’s statement, its margin on earnings before interest, taxes, depreciation, and amortisation slipped to 35 percent from… January 24, 2023 12:32 IST
Gland Pharma shares fall 4% on Cenexi acquisition report; should you buy, hold or sell? Gland Pharma’s Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development… November 30, 2022 12:11 IST
Gland Pharma share price tanks 12% to hit 52-week low on weak Q1 results; stock may top Rs 3000 to rally 24% At least two research and brokerage firms — Motilal Oswal Financial Services and YES Securities are bullish on Gland Pharma… Updated: July 21, 2022 16:01 IST
Investor – Gland Pharma: Maintain ‘buy’; margins to be steady Gland has a relatively limited launched portfolio in the Rest-of-World Market and India, which will expand to provide growth opportunities. March 29, 2022 01:30 IST
Man earns Rs 30 lakh salary, doesn’t file ITR; Income Tax Dept slaps Rs 3.74 lakh penalty — what ITAT said
‘Very uncertain global landscape’: Zoho’s Sridhar Vembu sounds stark warning about ‘job crisis’ in India